OCYNTIO

Serial Number 98491066
730

Registration Progress

Application Filed
Apr 9, 2024
Under Examination
Mar 25, 2025
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Mar 25, 2026 69 days

Trademark Image

OCYNTIO

Basic Information

Serial Number
98491066
Filing Date
April 9, 2024
Published for Opposition
January 28, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Sep 5, 2025
Application
Pending
Classes
005

Rights Holder

Actelion Pharmaceuticals Ltd

99
Address
Gewerbestrasse 16
Allschwil 4123
CH

Ownership History

Actelion Pharmaceuticals Ltd

Original Applicant
99
Allschwil CH

Actelion Pharmaceuticals Ltd

Owner at Publication
99
Allschwil CH

Legal Representation

Attorney
Danielle Rivera

USPTO Deadlines

Next Deadline
69 days remaining
NOA E-Mailed - SOU Required
Due Date
March 25, 2026
Extension Available
Until September 25, 2026

Application History

12 events
Date Code Type Description Documents
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 5, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 5, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 25, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 22, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical anti-allergic preparations and substances; vaccines

Classification

International Classes
005